Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide (Q37450632)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

title

Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

main subject

pharmacokinetics

1 reference

based on heuristic

inferred from title

author

Eric R Prossnitz

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

Jianquan Yang

object named as

Jianquan Yang

series ordinal

2

0 references

Larry Sklar

series ordinal

5

object named as

Larry A Sklar

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

author name string

Haixun Guo

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

Fabio Gallazzi

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

Yubin Miao

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

publication date

1 November 2009

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

published in

Bioconjugate Chemistry

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

volume

20

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

issue

11

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

page(s)

2162-2168

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

cites work

Cancer statistics, 2009

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

23 August 2017

Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

23 August 2017

203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

23 August 2017

111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

23 August 2017

Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

23 August 2017

64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

23 August 2017

99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

14 September 2017

Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

14 September 2017

Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

14 September 2017

Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

14 September 2017

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

14 September 2017

Evaluation of the Human Melanoma Targeting Properties of Radiolabeled α-Melanocyte Stimulating Hormone Peptide Analogues

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

14 September 2017

Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

28 September 2017

Specific receptors for alpha-melanocyte-stimulating hormone are widely distributed in tissues of rodents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

28 September 2017

Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

10 July 2018

Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

2 September 2018

Melanoma therapy via peptide-targeted {alpha}-radiation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

2 September 2018

A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

2 September 2018

In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786309

retrieved

2 September 2018

Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19817405

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19817405

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of a 177Lu-labeled DOTA conjugated alpha-melanocyte-stimulating hormone peptide in a murine melanoma-bearing mouse model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19817405

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1021/BC9003475

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

PMC publication ID

2786309

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

PubMed publication ID

19817405

1 reference

stated in

Europe PubMed Central

PMC publication ID

2786309

retrieved

20 August 2017

ResearchGate publication ID

26883274

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37450632&oldid=2143294854"